Chin-Sheng Hung

15PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer cell biologyBehavioural epidemiologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 13, 2026
Homer3 Promotes Aggressive Phenotypes in Triple-Negative Breast Cancer Through Cell Cycle- and MYC-Associated Programs.

|Jul 06, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.

|May 24, 2024
Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.

Hsieh-Tsung Shen, Chin-Sheng Hung, Clilia Davis

|May 27, 2023
The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity.

Chien-Yu Huang, Po-Li Wei, G M Shazzad Hossain Prince

|Jun 17, 2022
Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.

Ruo-Kai Lin, Chih-Ming Su, Shih-Yun Lin

|Feb 18, 2022
Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53.

Wei-Lin Wang, Uyanga Batzorig, Chin-Sheng Hung

Pageof 3

Frequent Collaborators

5 joint publications

Ruo-Kai Lin

4 joint publications

Yu-Jia Chang

3 joint publications

Po-Li Wei

3 joint publications

Uyanga Batzorig